Skip to main content
. Author manuscript; available in PMC: 2021 Mar 28.
Published in final edited form as: Nat Immunol. 2020 Sep 28;21(11):1456–1466. doi: 10.1038/s41590-020-0784-4

Extended Data Fig. 2. Flow cytometry gating strategy to define changes in Treg cell phenotype in arrayed Cas9 RNP screen.

Extended Data Fig. 2

(a) Initial gating strategy to identify live cells. (b) Gating strategy to assess Treg cell stability for personality and Scaffold plots. Control non-targeting Cas9 RNP-treated Treg cells (ctrl) after IL-12 conditioning are shown in light blue and FOXP3 KO Treg cells after IL-12 stimulation are shown in orange. a, b: Representative result for one non-targeting control Cas9 RNP in one out of two human blood donors. (c) % of live cells based on flow cytometry staining for all conditions tested in the arrayed Cas9 RNP screen.